Similarly, a genetic proxy for lowering triglycerides, the apoprotein C-III (APOC3) variant (OR = 1.174 [95% CI 1.054–1.307]; P = .003), was associated with an increased risk of SNHL. The gene discussed is APOC3; the disease is sensorineural hearing loss disorder.